• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.

作者信息

Lee Dong-Hwa

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.

出版信息

Diabetes Metab J. 2023 Jul;47(4):484-486. doi: 10.4093/dmj.2023.0165. Epub 2023 Jul 27.

DOI:10.4093/dmj.2023.0165
PMID:37533198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10404521/
Abstract
摘要

相似文献

1
The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.血糖控制对2型糖尿病合并慢性肾脏病患者不良结局的有益作用
Diabetes Metab J. 2023 Jul;47(4):484-486. doi: 10.4093/dmj.2023.0165. Epub 2023 Jul 27.
2
Management of type 2 diabetes in chronic kidney disease.2 型糖尿病合并慢性肾脏病的管理。
BMJ Open Diabetes Res Care. 2021 Jul;9(1). doi: 10.1136/bmjdrc-2021-002300.
3
[Metformin is commonly used in patients with renal impairment].二甲双胍常用于肾功能损害患者。
Dtsch Med Wochenschr. 2015 Nov;140(22):1656. doi: 10.1055/s-0041-106280. Epub 2015 Nov 4.
4
[Diabetes management issues for patients with chronic kidney disease].[慢性肾脏病患者的糖尿病管理问题]
Nephrol Ther. 2012 Jun;8(3):135-40. doi: 10.1016/j.nephro.2011.07.410. Epub 2011 Oct 20.
5
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.达格列净对伴有和不伴有糖尿病的慢性肾脏病患者的主要不良肾脏和心血管事件的影响：来自 DAPA-CKD 试验的预先指定分析。
Lancet Diabetes Endocrinol. 2021 Jan;9(1):22-31. doi: 10.1016/S2213-8587(20)30369-7.
6
Non-albuminuric chronic kidney disease in diabetes: A different approach?糖尿病中的非白蛋白尿性慢性肾脏病：一种不同的方法？
Indian J Med Res. 2022 Oct-Nov;156(4&5):685-686. doi: 10.4103/ijmr.ijmr_1018_22.
7
Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom.英国一项基于初级保健数据的队列研究：慢性肾脏病定义对新诊断 1 型和 2 型糖尿病患者发病和风险因素评估的影响。
Prim Care Diabetes. 2020 Aug;14(4):381-387. doi: 10.1016/j.pcd.2019.11.002. Epub 2019 Nov 30.
8
Acute and chronic kidney complications in children with type 1 diabetes mellitus.1 型糖尿病儿童的急性和慢性肾脏并发症。
Pediatr Nephrol. 2023 May;38(5):1449-1458. doi: 10.1007/s00467-022-05689-w. Epub 2022 Jul 27.
9
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis.在患有 2 型糖尿病和慢性肾病的患者中，使用非奈利酮与治疗后肺炎和 COVID-19 不良事件减少相关：FIDELITY 汇总二次分析。
JAMA Netw Open. 2022 Oct 3;5(10):e2236123. doi: 10.1001/jamanetworkopen.2022.36123.
10
Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes.白蛋白尿的变化可作为糖尿病患者心血管和肾脏结局的替代终点。
Diabetes Obes Metab. 2023 Jun;25(6):1434-1443. doi: 10.1111/dom.15030. Epub 2023 Mar 8.

本文引用的文献

1
Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD.慢性肾脏病 2 型糖尿病患者的血糖控制与不良临床结局：来自 KNOW-CKD 的结果。
Diabetes Metab J. 2023 Jul;47(4):535-546. doi: 10.4093/dmj.2022.0112. Epub 2023 Apr 25.
2
6. Glycemic Targets: Standards of Care in Diabetes-2023.6. 血糖目标：2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
3
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States.《美国肾脏数据系统2020年年报：美国肾脏疾病流行病学》
Am J Kidney Dis. 2021 Apr;77(4 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2021.01.002.
4
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline.慢性肾脏病中的糖尿病管理：2020KDIGO 临床实践指南概要。
Ann Intern Med. 2021 Mar;174(3):385-394. doi: 10.7326/M20-5938. Epub 2020 Nov 10.
5
Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus.老年2型糖尿病患者慢性肾脏病的患病率及进展率更高。
Diabetes Metab J. 2018 Jun;42(3):224-232. doi: 10.4093/dmj.2017.0065. Epub 2018 May 31.
6
Extreme Levels of HbA1c Increase Incident ESRD Risk in Chinese Patients with Type 2 Diabetes: Competing Risk Analysis in National Cohort of Taiwan Diabetes Study.糖化血红蛋白（HbA1c）极高水平增加中国2型糖尿病患者发生终末期肾病（ESRD）的风险：台湾糖尿病研究全国队列中的竞争风险分析
PLoS One. 2015 Jun 22;10(6):e0130828. doi: 10.1371/journal.pone.0130828. eCollection 2015.
7
The link between chronic kidney disease and cardiovascular disease.慢性肾病与心血管疾病之间的联系。
J Nephropathol. 2014 Jul;3(3):99-104. doi: 10.12860/jnp.2014.19. Epub 2014 Jul 1.
8
Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.糖尿病合并慢性肾脏病患者血糖控制与不良结局之间的关联：一项基于人群的队列研究。
Arch Intern Med. 2011 Nov 28;171(21):1920-7. doi: 10.1001/archinternmed.2011.537.
9
Temporal trends in the prevalence of diabetic kidney disease in the United States.美国糖尿病肾病患病率的时间趋势。
JAMA. 2011 Jun 22;305(24):2532-9. doi: 10.1001/jama.2011.861.
10
Glycated haemoglobin and the incidence of end-stage renal disease in diabetics.糖化血红蛋白与糖尿病患者终末期肾病的发生。
Nephrol Dial Transplant. 2011 Jul;26(7):2238-44. doi: 10.1093/ndt/gfq707. Epub 2010 Nov 23.